9 reports

  • 2.1 Overview of Anticoagulants
  • 2.1.2 Novel Oral Anticoagulants

Scope of the Report The report entitled “Global Anticoagulants Market (2018-2022 Edition)” provides an in-depth analysis of the global anticoagulants market with description of market size and growth. The analysis include market share by treatment, by segment, and by products. The report also provides an analysis...

  • Anticoagulant
  • United States
  • World
  • Bayer AG
  • Daiichi Sankyo Company
  • Approved anticoagulants in US
  • Anticoagulants pipeline portfolio

About the Anti-Coagulant Drugs Market Anticoagulants have been used for over 80 years to treat clotting disorders. It is used as a first line of defense for disorders such as deep vein thrombosis (DVT), pulmonary embolism, AF, and acute coronary syndrome. With the advent of time, traditional therapies are replaced by novel oral anticoagulants,...

  • Anticoagulant
  • United States
  • Boehringer Ingelheim GmbH
  • Johnson & Johnson
  • Sanofi S.A.

The study analyzes (##) select antithrombotic/ anticoagulant drugs for treating various thrombotic diseases in coronary artery disease, peripheral vascular disease, valvular heart disease, congestive heart failure and many others; (##) the marketing of these drugs in the global m

  • Anticoagulant
  • Therapy
  • World
  • Market Shares
  • JCS GUIDELINE RECOMMENDATIONS FOR CHOOSING AN ANTICOAGULANT
  • CCS GUIDELINE RECOMMENDATIONS FOR CHOOSING AN ANTICOAGULANT

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Various therapeutic options are available to treat patients with atrial fibrillation (AF), and most patients will receive some form of antithrombotic therapy, a heart rate control agent, and potentially, an antiarrhythmic drug...

  • Anticoagulant
  • Market Size
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company

GLOBAL ANTITHROMBOTIC DRUGS MARKET FORECAST 2018-2026 ##.

  • Anticoagulant
  • Therapy
  • World

Provexis Plc (UK) ##.

  • Anticoagulant
  • Cardiovascular Drug
  • Therapy
  • World
  • Market Shares

MARKET ##.

  • Anticoagulant
  • APAC
  • Japan
  • World
  • Company Sales
  • TAP-ANV - DRUG PROFILE
  • JOHNSON & JOHNSON

Thromboembolism - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Thromboembolism - Pipeline Review, H1 2018, provides an overview of the Thromboembolism (Cardiovascular) pipeline landscape. When a blood clot (thrombus) breaks...

  • Anticoagulant
  • Hospital
  • Pharmaceutical
  • United States
  • Product Initiative
  • Other Developmental Activities

Pulmonary Embolism - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism - Pipeline Review, H2 2017, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape. Pulmonary embolism is the sudden blockage...

  • Anticoagulant
  • Compression Therapy
  • United States
  • Product Initiative
  • Daiichi Sankyo Company